Sylvain Carras

14PUBLICATIONS
76CO-AUTHORS
Haematological tumoursPredictive and prognostic markersNanomedicineCancer therapy (excl. chemotherapy and radiation therapy)Disease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Apr 14, 2026
Interim assessment by circulating tumor DNA in primary mediastinal large B-cell lymphoma: a multicenter LYSA study.

Vincent Camus, Daphné Krzisch, Alessio Bruscaggin

|Nov 03, 2025
Synthetic control arm from mixed clinical trials and real-world data from the LYSA group for untreated diffuse large B-cell lymphoma patients aged over 80 years: a bona fide strategy for innovative clinical trials.

Valentin Letailleur, Isabelle Chaillol, Fanny Cherblanc

|Oct 22, 2025
Late failure of aggressive B-cell lymphoma after CAR T-cell therapy: a LYSA study from the DESCAR-T registry.

Federico Erbella, Emmanuel Bachy, Guillaume Cartron

|Sep 17, 2025
Drug development in MZL: caring for the forgotten child.

Catherine Thieblemont, Sylvain Carras, Côme Bommier

|Aug 04, 2025
Brentuximab vedotin addition to gemcitabine in relapsed or refractory peripheral T-cell lymphoma: a LYSA phase 2 study.

Olivier Tournilhac, Kamal Bouabdallah, Solène Lecolant

|May 06, 2025
Comparison of Electronic Surveillance With Routine Monitoring for Patients With Lymphoma at High Risk of Relapse: Prospective Randomized Controlled Phase 3 Trial (Sentinel Lymphoma).

Katell Le Dû, Adrien Chauchet, Sophie Sadot-Lebouvier

Pageof 3

Frequent Collaborators

7 joint publications

Franck Morschhauser

5 joint publications

Emmanuel Bachy

5 joint publications

Stéphanie Guidez

4 joint publications

Sylvain Choquet